Viral Clearance Strategies for Biopharmaceutical Safety

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-06-02-2001, Volume 25, Issue 6

Special considerations and cautions must be adhered to when designing virus safety studies and developing appropriate virus contamination control programs.

Related Content:

AnalyticsBiologic DrugsProcess ValidationManufacturingProcess DevelopmentDevelopmentDosage FormsViral ClearanceManufacturing, Separation and PurificationPharmaceutical Technology-06-02-2001
With New Funding, Orbis Medicines to Develop Oral Macrocycles as Alternative to Biologic Drugs
Using Continuous Processes and Automation to Remove Contamination Risk
Takeda Receives Japanese Regulatory Approval for HYQVIA Subcutaneous Injection for Treating Agammaglobulinemia or Hypogammaglobulinemia